DuPage Medical Group /ID# 18861 — Wheaton, Illinois

DuPage Medical Group /ID# 18861 is a clinical research site located in Wheaton, Illinois, United States 60189-3801.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

DuPage Medical Group /ID# 18861 has participated in 1 clinical trials.

Therapeutic areas: Chronic Plaque Psoriasis.

Sponsors: AbbVie.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Wheaton

Browse all research sites in Illinois · View every site in Wheaton

• Marionjoy Rehabilitation Hospital
• Marianjoy Hospital
• Marianjoy Rehabilitation Hospital
• Northwestern Medicine Marianjoy Rehabilitation Hospital
• GSK Investigational Site
• Research Site
• DuPage Medical Group /ID# 20507
• Marianjoy Rehabilitation
• Wheaton Eye Clinic
• Accellacare Duly Health and Care
• Atd002 52018

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for DuPage Medical Group /ID# 18861?

DuPage Medical Group /ID# 18861 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has DuPage Medical Group /ID# 18861 conducted?

DuPage Medical Group /ID# 18861 has 1 clinical trials on record. Their work covers Chronic Plaque Psoriasis.

Is DuPage Medical Group /ID# 18861 accredited by Crixeo Clinical Trials?

DuPage Medical Group /ID# 18861 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about DuPage Medical Group /ID# 18861?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.